Clinical Trials Directory

Trials / Completed

CompletedNCT00689377

Prevalence of Peripheral Arterial Disease in Subject With a Moderate Risk of Cardiovascular (CV) Disease (CVD) in Primary Prevention

Prevalence of Peripheral Arterial Disease in Subjects With a Moderate CVD Risk, With No Overt Vascular Diseases nOR diAbetes Mellitus

Status
Completed
Phase
Study type
Observational
Enrollment
9,000 (actual)
Sponsor
AstraZeneca · Industry
Sex
All
Age
45 Years
Healthy volunteers
Not accepted

Summary

Non interventional study aimed to establish the prevalence of lower extremity peripheral arterial disease (PAD), defined as an ankle-brachial index (ABI) not above 0.90 in subjects with a moderate risk of cardiovascular disease, with no overt cardiovascular diseases nor diabetes mellitus.

Conditions

Timeline

Start date
2007-05-01
Primary completion
2008-07-01
Completion
2008-07-01
First posted
2008-06-03
Last updated
2012-03-20

Locations

331 sites across 6 countries: Belgium, France, Greece, Italy, Netherlands, Switzerland

Source: ClinicalTrials.gov record NCT00689377. Inclusion in this directory is not an endorsement.

Prevalence of Peripheral Arterial Disease in Subject With a Moderate Risk of Cardiovascular (CV) Disease (CVD) in Primar (NCT00689377) · Clinical Trials Directory